Moleculin Biotech (NASDAQ:MBRX) Now Covered by StockNews.com
Research analysts at StockNews.com initiated coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Get Free Report) in a note issued to investors on Friday. The firm set a “sell” rating on the stock. Separately, HC Wainwright reiterated a “buy” rating and set a $3.00 target price on shares of Moleculin Biotech in a research report […]
More Stories
Border Czar: ICE to Assist at Airports Until They Are 100 Percent, TSA Pay Coming This Week
By Tom Gantert White House border czar Tom Homan said Sunday that ICE agents will be used to help out...
Trump Signals Potential Military Action Coming Against Cuba
By Jack Phillips President Donald Trump again suggested that U.S. military action could be coming against Cuba as his administration...
US Monitoring Surge in China’s Detention of Panama-Flagged Vessels
By Aldgra Fredly The U.S. Federal Maritime Commission on March 26 accused China of detaining Panama-flagged vessels in response to...
FBI Director Kash Patel Hacked by Iran-Linked Group
By Jacki Thrapp FBI Director Kash Patel’s personal email inbox was accessed by Iran-based hackers. “The FBI is aware of...
Block CFO Defends Job Cuts Due to AI Adaptation; Silicon Valley Executives Predict Increased Mass Layoffs
By Dylan Morgan Block’s Chief Financial Officer and Chief Operating Officer Amrita Ahuja defended the San Francisco-based payments company’s mass...
Houthis Enter Iran War With Missile Attack on Israel
By Tom Ozimek A spokesman for the Iran-aligned Houthi terrorist organization in Yemen said on March 28 that the group...